ResearcherShanghai Jiao Tong UniversityNo recent work listed

Shaohua Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5232-5902; OpenAlex author ID A5085338780. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 2 papers

Papers 2

High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression. Last author DOI 10.1016/j.heliyon.2023.e22584 ↗
BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer. Co-author DOI 10.1038/s41598-023-43577-x ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenxin Qi · 2 shared papers, 2023 · strength 0.35
- Paper High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer pr… DOI 10.1016/j.heliyon.2023.e22584 ↗
- Paper BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer. DOI 10.1038/s41598-023-43577-x ↗
Yihao Liu · 1 shared paper, 2023 · strength 0.18
- Paper High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer pr… DOI 10.1016/j.heliyon.2023.e22584 ↗
Yihao Liu · 1 shared paper, 2023 · strength 0.18
- Paper BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer. DOI 10.1038/s41598-023-43577-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.